Literature DB >> 19047483

Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: differing responses to dietary benzo[a]pyrene as proof of principle.

Hongbin Dong1, Timothy P Dalton, Marian L Miller, Ying Chen, Shigeyuki Uno, Zhanquan Shi, Howard G Shertzer, Seema Bansal, Narayan G Avadhani, Daniel W Nebert.   

Abstract

In the past, CYP1A1 protein was known to be located in the endoplasmic reticulum (ER; microsomes). More recently, CYP1A1 was shown also to be targeted to the inner mitochondrial membrane; mitochondrial import is dependent on NH(2)-terminal processing that exposes a cryptic targeting signal. It is interesting that microsomal and mitochondrial CYP1A1 enzymes exhibit different substrate specificities, electron donors, and inducer properties. To understand the physiological functions of microsomal versus mitochondrial CYP1A1, we have generated three knock-in lines by altering the CYP1A1 NH(2) terminus. Cyp1a1(mtt/mtt) mice encode an NH(2)-terminal 31-amino acid-truncated protein, deleting the ER-targeting signal and exposing the cryptic mitochondrial-targeting signal. Cyp1a1(mtp/mtp) mice encode a protein carrying L7N and L17N mutations; this mutant lacks the signal recognition particle (SRP)-binding site and subsequent ER-targeting, but requires proteolysis by a cytosolic peptidase for mitochondrial import. Cyp1a1(mc/mc) mice encode a microsomal protein having R34D and K39I mutations, which abolish the mitochondrial targeting signal. After dioxin or beta-naphthoflavone treatment of these mouse lines, the CYP1A1 protein was shown to be located in the mitochondria of the Cyp1a1(mtp/mtp) and Cyp1a1(mtt/mtt) lines and in microsomes of the Cyp1a1(mc/mc) line. To test for differences in function, we compared the response to dietary benzo[a]pyrene (BaP). After 18 days of daily oral BaP, wild-type and Cyp1a1(mc/mc) mice were completely protected, whereas Cyp1a1(-/-) and Cyp1a1(mtp/mtp) mice showed striking toxicity and compensatory up-regulation of CYP1A2 and CYP1B1 mRNA in several tissues. Our data support the likelihood that it is the microsomal rather than mitochondrial CYP1A1 enzyme that protects against oral BaP toxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19047483      PMCID: PMC2684908          DOI: 10.1124/mol.108.051888

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  58 in total

1.  Constitutive and inducible cytochromes P450 in rat lung mitochondria: xenobiotic induction, relative abundance, and catalytic properties.

Authors:  S V Bhagwat; J Mullick; H Raza; N G Avadhani
Journal:  Toxicol Appl Pharmacol       Date:  1999-05-01       Impact factor: 4.219

2.  Physiological role of the N-terminal processed P4501A1 targeted to mitochondria in erythromycin metabolism and reversal of erythromycin-mediated inhibition of mitochondrial protein synthesis.

Authors:  H K Anandatheerthavarada; C Vijayasarathy; S V Bhagwat; G Biswas; J Mullick; N G Avadhani
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

3.  Localization of multiple forms of inducible cytochromes P450 in rat liver mitochondria: immunological characteristics and patterns of xenobiotic substrate metabolism.

Authors:  H K Anandatheerthavarada; S Addya; R S Dwivedi; G Biswas; J Mullick; N G Avadhani
Journal:  Arch Biochem Biophys       Date:  1997-03-01       Impact factor: 4.013

4.  Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction.

Authors:  W P Long; M Pray-Grant; J C Tsai; G H Perdew
Journal:  Mol Pharmacol       Date:  1998-04       Impact factor: 4.436

Review 5.  Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor.

Authors:  Oliver Hankinson
Journal:  Arch Biochem Biophys       Date:  2005-01-15       Impact factor: 4.013

Review 6.  Ah receptor signals cross-talk with multiple developmental pathways.

Authors:  Alvaro Puga; Craig R Tomlinson; Ying Xia
Journal:  Biochem Pharmacol       Date:  2004-09-27       Impact factor: 5.858

Review 7.  Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease.

Authors:  E Tanaka
Journal:  J Clin Pharm Ther       Date:  1998-06       Impact factor: 2.512

8.  Mixed anionic detergent/aliphatic alcohol-polyacrylamide gel electrophoresis alters the separation of proteins relative to conventional sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  E G Brown
Journal:  Anal Biochem       Date:  1988-10       Impact factor: 3.365

9.  Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage.

Authors:  J Y Park; M K Shigenaga; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Targeting of NH2-terminal-processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondrial P450MT2.

Authors:  S Addya; H K Anandatheerthavarada; G Biswas; S V Bhagwat; J Mullick; N G Avadhani
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

View more
  24 in total

1.  Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice.

Authors:  Jun Ozeki; Shigeyuki Uno; Michitaka Ogura; Mihwa Choi; Tetsuyo Maeda; Kenichi Sakurai; Sadanori Matsuo; Sadao Amano; Daniel W Nebert; Makoto Makishima
Journal:  Toxicology       Date:  2010-11-21       Impact factor: 4.221

Review 2.  Bimodal targeting of microsomal cytochrome P450s to mitochondria: implications in drug metabolism and toxicity.

Authors:  Michelle C Sangar; Seema Bansal; Narayan G Avadhani
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10       Impact factor: 4.481

Review 3.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

4.  Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress.

Authors:  Seema Bansal; Chuan-Peng Liu; Naresh B V Sepuri; Hindupur K Anandatheerthavarada; Venkatesh Selvaraj; Jan Hoek; Ginger L Milne; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

Review 5.  Clinical effects of chemical exposures on mitochondrial function.

Authors:  Zarazuela Zolkipli-Cunningham; Marni J Falk
Journal:  Toxicology       Date:  2017-07-27       Impact factor: 4.221

6.  Comprehensive analysis of genetic variations in strictly-defined Leber congenital amaurosis with whole-exome sequencing in Chinese.

Authors:  Shi-Yuan Wang; Qi Zhang; Xiang Zhang; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

7.  Low-dose synergistic immunosuppression of T-dependent antibody responses by polycyclic aromatic hydrocarbons and arsenic in C57BL/6J murine spleen cells.

Authors:  Qian Li; Fredine T Lauer; Ke Jian Liu; Laurie G Hudson; Scott W Burchiel
Journal:  Toxicol Appl Pharmacol       Date:  2010-03-28       Impact factor: 4.219

8.  Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease.

Authors:  Prachi Bajpai; Michelle C Sangar; Shilpee Singh; Weigang Tang; Seema Bansal; Goutam Chowdhury; Qian Cheng; Ji-Kang Fang; Martha V Martin; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

9.  Human cytochrome P450 2E1 mutations that alter mitochondrial targeting efficiency and susceptibility to ethanol-induced toxicity in cellular models.

Authors:  Seema Bansal; Hindupur K Anandatheerthavarada; Govindaswamy K Prabu; Ginger L Milne; Martha V Martin; F Peter Guengerich; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

Review 10.  Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.

Authors:  Vasilis P Androutsopoulos; Aristidis M Tsatsakis; Demetrios A Spandidos
Journal:  BMC Cancer       Date:  2009-06-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.